Search Results - "Chun-Ling Huang"

Refine Results
  1. 1

    M2b macrophage subset decrement as an indicator of cognitive function in Alzheimer's disease by Hsieh, Sun‐Wung, Huang, LingChun, Chang, Yang‐Pei, Hung, Chih‐Hsing, Yang, Yuan‐Han

    Published in Psychiatry and clinical neurosciences (01-07-2020)
    “…Aim Alzheimer's disease (AD) is a chronic neurodegenerative disease. Various inflammatory processes account for the pathology of AD, and macrophages in…”
    Get full text
    Journal Article
  2. 2

    Predictors of caregiver burden in aged caregivers of demented older patients by Tsai, Chia-Fen, Hwang, Wei-Shen, Lee, Jun-Jun, Wang, Wen-Fu, Huang, Ling-Chun, Huang, Li-Kai, Lee, Wei-Ju, Sung, Pi-Shan, Liu, Yi-Chien, Hsu, Chih-Cheng, Fuh, Jong-Ling

    Published in BMC geriatrics (14-01-2021)
    “…Dementia in the oldest-old is projected to increase exponentially as is the burden of their caregivers who may experience unique challenges and suffering…”
    Get full text
    Journal Article
  3. 3

    Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis? by Huang, Ling-Chun, Chang, Yu-Han, Yang, Yuan-Han

    Published in Neurotherapeutics (01-07-2019)
    “…Disease-modifying anti-rheumatic drugs (DMARDs) can reduce inflammation and slow progression of rheumatoid arthritis (RA). It remains unknown what impact…”
    Get full text
    Journal Article
  4. 4

    Association between subclinical epileptiform discharge and the behavioral and psychological symptoms in patients with Alzheimer's dementia by Yeh, Wei‐Chih, Hsu, Chung‐Yao, Li, Kuan‐Ying, Chien, Ching‐Fang, Huang, LingChun, Yang, Yuan‐Han

    “…Behavioral and psychological symptoms of dementia (BPSD) and subclinical epileptiform discharge (SED) increase with the progression of Alzheimer's disease. In…”
    Get full text
    Journal Article
  5. 5

    The Long-term Effects of Immersive Virtual Reality Reminiscence in People With Dementia: Longitudinal Observational Study by Huang, Ling-Chun, Yang, Yuan-Han

    Published in JMIR serious games (25-07-2022)
    “…Background: Novel nonpharmacological therapies are being developed to prevent cognitive decline and reduce behavioral and psychological symptoms in patients…”
    Get full text
    Journal Article
  6. 6

    Cognitive effects of cilostazol in Alzheimer's dementia patients with peripheral arterial occlusive disease: A case–control study by Chien, Ching‐Fang, Huang, LingChun, Li, Kuan‐Ying, Yang, Yuan‐Han

    Published in Geriatrics & gerontology international (01-03-2023)
    “…Aim Alzheimer's dementia (AD) is a slowly progressing neurodegenerative disease, characterized by beta‐amyloid deposition and neurofibrillary tangles…”
    Get full text
    Journal Article
  7. 7

    Behavioral and psychological symptoms in institutional residents with dementia in Taiwan by Hsieh, Sun‐Wung, Huang, LingChun, Hsieh, Tsung‐Jen, Lin, Chung‐Fen, Hsu, Chih‐Cheng, Yang, Yuan‐Han

    Published in Geriatrics & gerontology international (01-08-2021)
    “…Aim Behavioral and psychological symptoms of dementia (BPSD) are important predictors for institutional placement, caregiver distress and depression for…”
    Get full text
    Journal Article
  8. 8

    Predictors of Carotid Intima-Media Thickness and Plaque Progression in a Chinese Population by Huang, Ling-Chun, Lin, Ruey-Tay, Chen, Chien-Fu, Chen, Chun-Hung, Juo, Suh-Hang Hank, Lin, Hsiu-Fen

    Published in Journal of Atherosclerosis and Thrombosis (01-01-2016)
    “…Aim: Atherosclerotic diseases are the leading cause of death worldwide. Longitudinal changes in carotid intima-media thickness (IMT) and plaque are being…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Gender differences in presentation of behavioral and psychological symptoms in Alzheimer's disease in Taiwan by Hsieh, Sun-Wung, Chen, Chun-Hung, Huang, Ling-Chun, Chang, Yu-Han, Yang, Yuan-Han

    Published in Aging & mental health (02-08-2020)
    “…Objectives: Behavioral and psychological symptoms of dementia (BPSD) are frequently met in Alzheimer's disease (AD), especially in their late stages. BPSD has…”
    Get full text
    Journal Article
  11. 11

    Age and sex differences in the association between APOE genotype and Alzheimer’s disease in a Taiwan Chinese population by Huang, Ling-Chun, Lee, Mei-Yueh, Chien, Ching-Fang, Chang, Yang-Pei, Li, Kuan-Ying, Yang, Yuan-Han

    Published in Frontiers in aging neuroscience (23-08-2023)
    “…The Apolipoprotein E (APOE) epsilon (ɛ) 4 allele is a well-established risk factor for late-onset Alzheimer's disease (AD). Reports on white ancestry…”
    Get full text
    Journal Article
  12. 12

    Skinfold thickness for rivastigmine patch application in Alzheimer’s disease by Chou, Ping-Song, Jhang, Kai-Ming, Huang, Ling-Chun, Wang, Wen-Fu, Yang, Yuan-Han

    Published in Psychopharmacology (01-04-2019)
    “…Rationale Rivastigmine patches are used for patients with Alzheimer’s disease (AD), but little is known about the serum concentration of rivastigmine and its…”
    Get full text
    Journal Article
  13. 13

    Plasma biomarkers and their correlation in adult children of parents with Alzheimer’s disease by Huang, Ling-Chun, Chen, Ming-Hui, Chuu, Chih-Pin, Li, Kuan-Ying, Hour, Tzyh-Chyuan, Yang, Yuan-Han

    Published in Frontiers in aging neuroscience (30-08-2022)
    “…Family history (FH) of late-onset Alzheimer’s disease (AD) is associated with changes in several cerebrospinal fluid (CSF) biomarkers in cognitively normal…”
    Get full text
    Journal Article
  14. 14

    Tyrosinase inhibitory and antioxidant activities of three Bifidobacterium bifidum-fermented herb extracts by Wang, Guey-Horng, Chen, Chih-Yu, Lin, Chia-Pei, Huang, Chun-Ling, Lin, Chia-hui, Cheng, Chiu-Yu, Chung, Ying-Chien

    Published in Industrial crops and products (30-10-2016)
    “…•Chinese herb extracts are potentially used for developing new cosmetic ingredients.•Fermentation enhances physiological and biochemical activities of herb…”
    Get full text
    Journal Article
  15. 15

    Impact of the CYP2D6 single nucleotide polymorphism on the concentration of and therapeutic response to donepezil in mild-to-moderate Alzheimer's disease by Chou, Ping-Song, Huang, Ling-Chun, Hour, Tzyh-Chyuan, Yen, Chen-Wen, Yang, Yuan-Han

    “…Donepezil was approved for the treatment of Alzheimer's disease (AD) but causes variable therapeutic responses. Thus, identifying specific genetic…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Application of Micro-Western Array for Identifying Different Serum Protein Expression Profile among Healthy Control, Alzheimer’s Disease Patients and Patients’ Adult Children by Huo, Chieh, Chen, Ming-Hui, Hour, Tzyh-Chyuan, Huang, Ling-Chun, Fong, Yi-On, Kuo, Ying-Yu, Yang, Yuan-Han, Chuu, Chih-Pin

    Published in Brain sciences (26-08-2022)
    “…(1) Background: Alzheimer’s disease (AD) is the most common form of dementia. Increased levels of inflammatory proteins have been observed in brain and plasma…”
    Get full text
    Journal Article
  18. 18

    Prevalence and Risk Factors of Neuropsychiatric Symptoms in Institutionalized Patients with Parkinson's Disease in Taiwan: A Nationwide Observational Study by Chang, Yang-Pei, Chien, Ching-Fang, Hsieh, Sun-Wung, Huang, Ling-Chun, Lin, Chung-Fen, Hsu, Chih-Cheng, Yang, Yuan-Han

    Published in Healthcare (Basel) (13-01-2023)
    “…Neuropsychiatric symptoms (NPSs) are known to be frequent in Parkinson's disease (PD) with great impacts on the quality of life, but reports about the…”
    Get full text
    Journal Article
  19. 19

    Association between Cerebral Coordination Functions and Clinical Outcomes of Alzheimer's Dementia by Yang, Yuan-Han, Lee, Ying-Han, Yen, Chen-Wen, Huang, Ling-Chun, Chang, Yang-Pei, Chien, Ching-Fang

    Published in Brain sciences (09-10-2022)
    “…Background: Alzheimer’s dementia (AD) is a degenerative disease that impairs cognitive function, initially, and then motor or other function, eventually. Motor…”
    Get full text
    Journal Article
  20. 20

    Dynamic Blood Concentrations of Aβ1–40 and Aβ1–42 in Alzheimer’s Disease by Yang, Yuan-Han, Huang, Ling-Chun, Hsieh, Sun-Wung, Huang, Li-Ju

    “…Amyloid-beta (Aβ) is produced by the cleavage of amyloid precursor proteins in the cell membrane by β-secretase and γ-secretase into a monomeric form with…”
    Get full text
    Journal Article